Abstract：
OBJECTIVE: To describe clinicians\' attitudes, knowledge and practice relating to the anti-müllerian hormone (AMH) test.
METHODS: Cross-sectional nationwide survey.
METHODS: Australia.
METHODS: A total of 362 general practitioners (GPs), gynaecologists and reproductive specialists.
METHODS: Clinicians were recruited through relevant professional organisations, with data collected from May 2021 to April 2022.
METHODS: Clinicians\' attitudes, knowledge and practice relating to the AMH test, measured using multiple choice, Likert scales and open-ended items.
RESULTS: Fifteen percent of GPs (n = 27) and 40% of gynaecologists and other specialists (n = 73) order at least one AMH test per month. Specialists reported raising the idea of testing most of the time, whereas GPs reported that patient request was more common. Half of clinicians lacked confidence interpreting (n = 182, 51%) and explaining (n = 173, 48%) an AMH result to their patients. Five percent (n = 19) believed the test was moderately/very useful in predicting natural conception/birth and 22% (n = 82) believed the same for predicting premature menopause, despite evidence that the test cannot reliably predict either. Forty percent (n = 144) had previously ordered the test to help with reproductive planning and 21% (n = 75) to provide reassurance about fertility.
CONCLUSIONS: Clinicians reported use of AMH testing in clinical circumstances not supported by the evidence. With the proliferation of direct-to-consumer testing, efforts to support clinicians in the judicious use of testing and effectively navigating patient requests are needed.
METHODS: Cross-sectional nationwide survey.
METHODS: Australia.
METHODS: A total of 362 general practitioners (GPs), gynaecologists and reproductive specialists.
METHODS: Clinicians were recruited through relevant professional organisations, with data collected from May 2021 to April 2022.
METHODS: Clinicians\' attitudes, knowledge and practice relating to the AMH test, measured using multiple choice, Likert scales and open-ended items.
RESULTS: Fifteen percent of GPs (n = 27) and 40% of gynaecologists and other specialists (n = 73) order at least one AMH test per month. Specialists reported raising the idea of testing most of the time, whereas GPs reported that patient request was more common. Half of clinicians lacked confidence interpreting (n = 182, 51%) and explaining (n = 173, 48%) an AMH result to their patients. Five percent (n = 19) believed the test was moderately/very useful in predicting natural conception/birth and 22% (n = 82) believed the same for predicting premature menopause, despite evidence that the test cannot reliably predict either. Forty percent (n = 144) had previously ordered the test to help with reproductive planning and 21% (n = 75) to provide reassurance about fertility.
CONCLUSIONS: Clinicians reported use of AMH testing in clinical circumstances not supported by the evidence. With the proliferation of direct-to-consumer testing, efforts to support clinicians in the judicious use of testing and effectively navigating patient requests are needed.
摘要：
目的：描述临床医生的态度，有关抗苗勒管激素（AMH）测试的知识和实践。
方法：全国横断面调查。
方法：澳大利亚。
方法：共362名全科医生，妇科医生和生殖专家。
方法：通过相关专业组织招募临床医生，数据收集自2021年5月至2022年4月。
方法：临床医生的态度，与AMH测试相关的知识和实践，使用多项选择测量，李克特秤和开放式物品。
结果：15％的全科医生（n=27）和40％的妇科医生和其他专家（n=73）每月至少进行一次AMH测试。专家报告说，大多数时候都提出了测试的想法，而全科医生报告患者要求更常见。一半的临床医生缺乏对患者的AMH结果解释（n=182，51％）和解释（n=173，48％）的信心。5％（n=19）认为该测试在预测自然受孕/出生方面中等/非常有用，而22％（n=82）认为该测试在预测过早绝经方面也是如此。尽管有证据表明该测试也不能可靠地预测。40％（n=144）之前曾下令进行测试以帮助进行生殖计划，而21％（n=75）则提供有关生育能力的保证。
结论：临床医生报告在没有证据支持的临床情况下使用AMH检测。随着直接面向消费者的测试的普及，需要努力支持临床医生明智地使用测试并有效地导航患者请求。
方法：全国横断面调查。
方法：澳大利亚。
方法：共362名全科医生，妇科医生和生殖专家。
方法：通过相关专业组织招募临床医生，数据收集自2021年5月至2022年4月。
方法：临床医生的态度，与AMH测试相关的知识和实践，使用多项选择测量，李克特秤和开放式物品。
结果：15％的全科医生（n=27）和40％的妇科医生和其他专家（n=73）每月至少进行一次AMH测试。专家报告说，大多数时候都提出了测试的想法，而全科医生报告患者要求更常见。一半的临床医生缺乏对患者的AMH结果解释（n=182，51％）和解释（n=173，48％）的信心。5％（n=19）认为该测试在预测自然受孕/出生方面中等/非常有用，而22％（n=82）认为该测试在预测过早绝经方面也是如此。尽管有证据表明该测试也不能可靠地预测。40％（n=144）之前曾下令进行测试以帮助进行生殖计划，而21％（n=75）则提供有关生育能力的保证。
结论：临床医生报告在没有证据支持的临床情况下使用AMH检测。随着直接面向消费者的测试的普及，需要努力支持临床医生明智地使用测试并有效地导航患者请求。
